We’re providing updates on the COVID-19 situation for the UK drug discovery community

Our aim is to help the community during this challenging time and also highlight important work and resources
Find out more >

× Medicines Discovery Catapult

Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.

We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed. 

We are helping to industrialise and drive the adoption of new techniques and technologies.

We are driven by helping our community make their mark on the industry and patients.

If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.

Latest News

No code, no problem: Chief.AI and Medicines Discovery Catapult harness the power of AI for new pay as you go drug discovery platform

Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as you go, AI platform for drug discovery – offering greater

Medicines Discovery Catapult welcomes new scientific and people leaders

Medicines Discovery Catapult (MDC) is proud to announce an extension to its talented workforce, further expanding the organisation’s expert R&D offer and adding over 80

MDC Seeks Buyer for Alderley Park Lighthouse Laboratory

Medicines Discovery Catapult (MDC) today (8 July 2021) announces its intention to sustain its Alderley Park Lighthouse Laboratory Diagnostics Testing facility (“AP Lighthouse Laboratory”) through

All News >